Alpha Biotech Ltd
XM-ONE, AbSorber's transplantation cross match, has proven to identify patients at risk of experiencing acute rejections after kidney transplantation. This was initially shown in 2009 when Breimer and co-workers published data from a multicenter study XM-ONE® (Breimer, M et al, Transplantation, Feb 2009). In a new publication from Johns Hopkins Medical School, Baltimore, MD (Jackson, AM et al, Transplantation, Apr 2011) these findings are confirmed.
AlphaBiotech Ltd endeavours to provide its customers with premium quality diagnostic, crystallography and laboratory automation products. We are committed to offering these items at competitive prices and with timely, care-free deliveries so that you can focus your efforts on your research or patient care.
Subscribe to the News Feed